Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Novo Nordisk's Pill, BMW's Struggle, Diageo Up | Stock Movers
Posted
May 6, 2026
Views
332
Likes
3
Engagement
0.90%
May 6, 2026
332
3
0.90%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
4:52Now PlayingToday's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Novo Nordisk’s new Wegovy obesity pill fueled sales in the first quarter and the drugmaker said this year’s declines won’t be as bad as expected, a relief for investors.
- BMW’s carmaking returns fell in the first quarter as intense competition in China weighed on prices and deliveries in the world’s biggest auto market.
- Diageo’s sales unexpectedly rose in the latest quarter as growth in Africa and Latin America was enough to offset significant weakness in the US.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Novo Nordisk's Pill, BMW's Struggle, Diageo Up
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
